Glucose metabolism and diet-based prevention of liver dysfunction in MPV17 mutant patients

Rossella Parini, Francesca Furlan, Luigi Notarangelo, Antonella Spinazzola, Graziella Uziel, Pietro Strisciuglio, Daniela Concolino, Carlo Corbetta, Gabriella Nebbia, Francesca Menni, Giorgio Rossi, Marco Maggioni, Massimo Zeviani

Research output: Contribution to journalArticle

Abstract

Background/Aims: To describe in detail the specific clinical and biological characteristics of three patients with MPV17 gene mutations, a rare hepatocerebral mitochondrial DNA depletion syndrome (MDS) and the positive effects of a novel dietetic treatment based on avoidance of fasting. Methods: We describe the case histories of three members of the same family with MPV17 mutations. Results: Two patients had a very severe and progressive liver disease: 1 died in the first year of life and the other underwent liver transplantation. The third patient, now 13 years of age, had a milder form of liver disease and developed progressive ataxia. Psychomotor involvement at onset of disease was mild or absent. No patient had severe hyperlactataemia. In vivo functional studies on two patients showed no hyperlactataemia even after intravenous and oral glucose loading, regular fasting hypoglycemia 3-4 h after meals and no response to glucagon. Liver function tests improved when patients received continuous iv glucose infusion or were regularly fed every 3 h. Conclusions: These clinical and biochemical features allow us to differentiate patients with MPV17 mutations from other liver MDS and suggest that regular glucose intake at short intervals may be beneficial in slowing the progression of the disease.

Original languageEnglish
Pages (from-to)215-221
Number of pages7
JournalJournal of Hepatology
Volume50
Issue number1
DOIs
Publication statusPublished - Jan 2009

Fingerprint

Liver Diseases
Diet
Glucose
Mitochondrial DNA
Mutation
Dietetics
Liver Function Tests
Ataxia
Glucagon
Hypoglycemia
Liver Transplantation
Meals
Disease Progression
Fasting
Liver
Genes

Keywords

  • Glucose metabolism
  • Mitochondrial diseases
  • Mitochondrial DNA depletion
  • MPV17

ASJC Scopus subject areas

  • Hepatology

Cite this

Parini, R., Furlan, F., Notarangelo, L., Spinazzola, A., Uziel, G., Strisciuglio, P., ... Zeviani, M. (2009). Glucose metabolism and diet-based prevention of liver dysfunction in MPV17 mutant patients. Journal of Hepatology, 50(1), 215-221. https://doi.org/10.1016/j.jhep.2008.08.019

Glucose metabolism and diet-based prevention of liver dysfunction in MPV17 mutant patients. / Parini, Rossella; Furlan, Francesca; Notarangelo, Luigi; Spinazzola, Antonella; Uziel, Graziella; Strisciuglio, Pietro; Concolino, Daniela; Corbetta, Carlo; Nebbia, Gabriella; Menni, Francesca; Rossi, Giorgio; Maggioni, Marco; Zeviani, Massimo.

In: Journal of Hepatology, Vol. 50, No. 1, 01.2009, p. 215-221.

Research output: Contribution to journalArticle

Parini, R, Furlan, F, Notarangelo, L, Spinazzola, A, Uziel, G, Strisciuglio, P, Concolino, D, Corbetta, C, Nebbia, G, Menni, F, Rossi, G, Maggioni, M & Zeviani, M 2009, 'Glucose metabolism and diet-based prevention of liver dysfunction in MPV17 mutant patients', Journal of Hepatology, vol. 50, no. 1, pp. 215-221. https://doi.org/10.1016/j.jhep.2008.08.019
Parini R, Furlan F, Notarangelo L, Spinazzola A, Uziel G, Strisciuglio P et al. Glucose metabolism and diet-based prevention of liver dysfunction in MPV17 mutant patients. Journal of Hepatology. 2009 Jan;50(1):215-221. https://doi.org/10.1016/j.jhep.2008.08.019
Parini, Rossella ; Furlan, Francesca ; Notarangelo, Luigi ; Spinazzola, Antonella ; Uziel, Graziella ; Strisciuglio, Pietro ; Concolino, Daniela ; Corbetta, Carlo ; Nebbia, Gabriella ; Menni, Francesca ; Rossi, Giorgio ; Maggioni, Marco ; Zeviani, Massimo. / Glucose metabolism and diet-based prevention of liver dysfunction in MPV17 mutant patients. In: Journal of Hepatology. 2009 ; Vol. 50, No. 1. pp. 215-221.
@article{61e2ed41f9704e618b1a24869aa5db87,
title = "Glucose metabolism and diet-based prevention of liver dysfunction in MPV17 mutant patients",
abstract = "Background/Aims: To describe in detail the specific clinical and biological characteristics of three patients with MPV17 gene mutations, a rare hepatocerebral mitochondrial DNA depletion syndrome (MDS) and the positive effects of a novel dietetic treatment based on avoidance of fasting. Methods: We describe the case histories of three members of the same family with MPV17 mutations. Results: Two patients had a very severe and progressive liver disease: 1 died in the first year of life and the other underwent liver transplantation. The third patient, now 13 years of age, had a milder form of liver disease and developed progressive ataxia. Psychomotor involvement at onset of disease was mild or absent. No patient had severe hyperlactataemia. In vivo functional studies on two patients showed no hyperlactataemia even after intravenous and oral glucose loading, regular fasting hypoglycemia 3-4 h after meals and no response to glucagon. Liver function tests improved when patients received continuous iv glucose infusion or were regularly fed every 3 h. Conclusions: These clinical and biochemical features allow us to differentiate patients with MPV17 mutations from other liver MDS and suggest that regular glucose intake at short intervals may be beneficial in slowing the progression of the disease.",
keywords = "Glucose metabolism, Mitochondrial diseases, Mitochondrial DNA depletion, MPV17",
author = "Rossella Parini and Francesca Furlan and Luigi Notarangelo and Antonella Spinazzola and Graziella Uziel and Pietro Strisciuglio and Daniela Concolino and Carlo Corbetta and Gabriella Nebbia and Francesca Menni and Giorgio Rossi and Marco Maggioni and Massimo Zeviani",
year = "2009",
month = "1",
doi = "10.1016/j.jhep.2008.08.019",
language = "English",
volume = "50",
pages = "215--221",
journal = "Journal of Hepatology",
issn = "0168-8278",
publisher = "Elsevier B.V.",
number = "1",

}

TY - JOUR

T1 - Glucose metabolism and diet-based prevention of liver dysfunction in MPV17 mutant patients

AU - Parini, Rossella

AU - Furlan, Francesca

AU - Notarangelo, Luigi

AU - Spinazzola, Antonella

AU - Uziel, Graziella

AU - Strisciuglio, Pietro

AU - Concolino, Daniela

AU - Corbetta, Carlo

AU - Nebbia, Gabriella

AU - Menni, Francesca

AU - Rossi, Giorgio

AU - Maggioni, Marco

AU - Zeviani, Massimo

PY - 2009/1

Y1 - 2009/1

N2 - Background/Aims: To describe in detail the specific clinical and biological characteristics of three patients with MPV17 gene mutations, a rare hepatocerebral mitochondrial DNA depletion syndrome (MDS) and the positive effects of a novel dietetic treatment based on avoidance of fasting. Methods: We describe the case histories of three members of the same family with MPV17 mutations. Results: Two patients had a very severe and progressive liver disease: 1 died in the first year of life and the other underwent liver transplantation. The third patient, now 13 years of age, had a milder form of liver disease and developed progressive ataxia. Psychomotor involvement at onset of disease was mild or absent. No patient had severe hyperlactataemia. In vivo functional studies on two patients showed no hyperlactataemia even after intravenous and oral glucose loading, regular fasting hypoglycemia 3-4 h after meals and no response to glucagon. Liver function tests improved when patients received continuous iv glucose infusion or were regularly fed every 3 h. Conclusions: These clinical and biochemical features allow us to differentiate patients with MPV17 mutations from other liver MDS and suggest that regular glucose intake at short intervals may be beneficial in slowing the progression of the disease.

AB - Background/Aims: To describe in detail the specific clinical and biological characteristics of three patients with MPV17 gene mutations, a rare hepatocerebral mitochondrial DNA depletion syndrome (MDS) and the positive effects of a novel dietetic treatment based on avoidance of fasting. Methods: We describe the case histories of three members of the same family with MPV17 mutations. Results: Two patients had a very severe and progressive liver disease: 1 died in the first year of life and the other underwent liver transplantation. The third patient, now 13 years of age, had a milder form of liver disease and developed progressive ataxia. Psychomotor involvement at onset of disease was mild or absent. No patient had severe hyperlactataemia. In vivo functional studies on two patients showed no hyperlactataemia even after intravenous and oral glucose loading, regular fasting hypoglycemia 3-4 h after meals and no response to glucagon. Liver function tests improved when patients received continuous iv glucose infusion or were regularly fed every 3 h. Conclusions: These clinical and biochemical features allow us to differentiate patients with MPV17 mutations from other liver MDS and suggest that regular glucose intake at short intervals may be beneficial in slowing the progression of the disease.

KW - Glucose metabolism

KW - Mitochondrial diseases

KW - Mitochondrial DNA depletion

KW - MPV17

UR - http://www.scopus.com/inward/record.url?scp=57049149030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=57049149030&partnerID=8YFLogxK

U2 - 10.1016/j.jhep.2008.08.019

DO - 10.1016/j.jhep.2008.08.019

M3 - Article

C2 - 19012992

AN - SCOPUS:57049149030

VL - 50

SP - 215

EP - 221

JO - Journal of Hepatology

JF - Journal of Hepatology

SN - 0168-8278

IS - 1

ER -